These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9696140)

  • 21. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome.
    Laperche S; Abuaf N; Meyer O; Carsique R; Deschamps A; Rajoely B; Johanet C; Homberg JC
    J Rheumatol; 1994 Sep; 21(9):1678-83. PubMed ID: 7799349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG; Baranov NG; Nasonov EL
    Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
    Cervera R; García-Carrasco M; Font J; Ramos M; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(4):361-5. PubMed ID: 9272295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS).
    Ceribelli A; Tincani A; Cavazzana I; Franceschini F; Cattaneo R; Pauley BA; Chan JY; Chan EK; Satoh M
    Autoimmunity; 2011 Mar; 44(2):90-7. PubMed ID: 20695766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Satoh A; Suzuki K; Takayama E; Kojima K; Hidaka T; Kawakami M; Matsumoto I; Ohsuzu F
    J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid syndromes with anti-human beta 2-glycoprotein I antibodies despite negative reactivity in conventional aPL and LA assays.
    Guérin V; Couchouron A; Vergnes C; Parrens E; Vernhes JP; Constans J; Boisseau M
    Thromb Haemost; 1997 May; 77(5):1037-8. PubMed ID: 9184427
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
    Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
    Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.
    Barquinero J; Ordi-Ros J; Selva A; Perez-Peman P; Vilardell M; Khamashta M
    Lupus; 1994 Feb; 3(1):55-8. PubMed ID: 8025588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome.
    Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG
    Lupus; 1999; 8(3):234-9. PubMed ID: 10342717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.